Search

everythinglearnresearchcommunity

for

Search:↓

Nanoparticles show potential for controlled release of hair loss drugs, improving treatment effectiveness.

The flutamide-loaded hydrogel is a promising, skin-friendly treatment for acne and hair loss, potentially requiring less frequent application.

The new oral testosterone pill normalized testosterone levels and lowered SHBG in men with low testosterone.

The gene URB is more active in human hair growth cells and responds to a hair-related hormone.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Dihydrotestosterone (DHT) mainly affects nearby cells, doesn't significantly change prostate hormonal environment or cancer risk, and doesn't play a main role in causing hair loss or acne. More research is needed on its effects on heart health, sexual function, and bone health.

Some natural remedies may help with hair regrowth, but more research is needed to confirm their effectiveness and safety.

The herbal hair emulgel was effective and stable for promoting hair growth, reducing dandruff, controlling hair fall, and preventing greying.

Protease Nexin-1 is found in human hair growth cells and is affected by male hormones.

Convolvulus arvensis ethanolic extract can potentially promote hair growth and reduce hair loss.

New treatment improves male hair loss.

Testosterone's muscle-building effects do not require its conversion to DHT.

Testosterone and dihydrotestosterone have similar effects on body composition and metabolic health in men.

Pre-operative hormone treatment for hypospadias surgery might improve outcomes, but more research is needed to confirm.

Hormone treatment before hypospadias surgery can increase penis size and reduce surgery complications.

Dutasteride more effectively lowers DHT levels in men with enlarged prostates than finasteride.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Finasteride effectively treats BPH, but needs more trials to understand potential.

Finasteride treats enlarged prostate and may help with baldness, but effects on sexual function and male fetuses are unclear.

Male pattern baldness involves hormones and cell signals affecting hair growth.

Testosterone treatment in trans men increases body and facial hair and may lead to hair loss over time, but severe skin issues are rare.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Hormones and metabolism play a complex role in prostate enlargement, and more research is needed to improve diagnosis and treatment.

Finasteride helps regrow hair and shrink prostate by reducing DHT, with some sexual side effects.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

Finasteride works better than Permixon in reducing dihydrotestosterone levels.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Finasteride reduces hair loss and treats BPH without major hormone changes, but may cause sexual dysfunction.